ENDRA Life Sciences (NDRA) Current Assets (2016 - 2026)

ENDRA Life Sciences has disclosed Current Assets across 11 years of filings, most recently posting $536666.0 for Q1 2026.

• In Q1 2026, Current Assets fell 75.38% year-over-year to $536666.0; the TTM figure through Mar 2026 stood at $536666.0 (down 75.38% YoY), while the FY2025 annual figure was $967969.0, down 71.81% from the prior year.
• Current Assets slipped to $536666.0 in Q1 2026, from $967969.0 in the prior quarter.
• Over the last five years, Current Assets for NDRA reached as high as $14.5 million in Q2 2022 and fell as low as $536666.0 in Q1 2026.
• The 5-year median for Current Assets is $5.0 million (2024), against an average of $5.2 million.
• The widest YoY moves for Current Assets: up 71.6% in 2025, down 78.87% in 2025.
• A 5-year view of Current Assets shows it stood at $5.4 million in 2022, then sank by 43.62% to $3.0 million in 2023, then climbed by 13.22% to $3.4 million in 2024, then plunged by 71.81% to $967969.0 in 2025, then plunged by 44.56% to $536666.0 in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $536666.0, $967969.0, and $1.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.